| 11/13/2026 11:47 AM | ARK Investment Management LLC (1697748) Filed by Recursion Pharmaceuticals (1601830) Subject | Form SCHEDULE 13G/A | |
| 11/10/2026 8:07 AM | Recursion Pharmaceuticals (1601830) Subject STATE STREET CORP (93751) Filed by STATE STREET CORP (93751) Filed by | Form SCHEDULE 13G | |
| 11/04/2026 4:11 PM | Hassan Fred (1110744) Reporting Recursion Pharmaceuticals (1601830) Issuer | Form 3 Initial statement of beneficial ownership of securities | |
| 11/04/2026 4:12 PM | Borgeson Blake (1856094) Reporting Recursion Pharmaceuticals (1601830) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 11/04/2026 4:12 PM | Hassan Fred (1110744) Reporting Recursion Pharmaceuticals (1601830) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 11/03/2026 10:24 AM | Borgeson Blake (1856094) Reporting Recursion Pharmaceuticals (1601830) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 11/02/2026 3:32 PM | Recursion Pharmaceuticals (1601830) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 11/02/2026 3:34 PM | Recursion Pharmaceuticals (1601830) Filer | Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
| 10/15/2026 4:31 PM | Recursion Pharmaceuticals (1601830) Filer | Form 424B5 | |
| 10/15/2026 7:46 AM | Recursion Pharmaceuticals (1601830) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 10/15/2026 7:19 AM | Recursion Pharmaceuticals (1601830) Filer | Form 424B5 | |
Get the Latest News and Ratings for RXRX and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Recursion Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.
|
| 10/07/2026 5:08 PM | HERSHBERG ROBERT (1274139) Reporting Recursion Pharmaceuticals (1601830) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 10/07/2026 5:08 PM | Borgeson Blake (1856094) Reporting Recursion Pharmaceuticals (1601830) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 10/06/2026 10:48 AM | Borgeson Blake (1856094) Reporting Recursion Pharmaceuticals (1601830) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 10/06/2026 10:09 AM | HERSHBERG ROBERT (1274139) Reporting Recursion Pharmaceuticals (1601830) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 10/02/2026 5:17 PM | Li Dean Y (1837016) Reporting Recursion Pharmaceuticals (1601830) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 10/02/2026 5:17 PM | Dar Zavain (1852075) Reporting Recursion Pharmaceuticals (1601830) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 09/21/2026 8:05 AM | Recursion Pharmaceuticals (1601830) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 09/16/2026 4:52 PM | Recursion Pharmaceuticals (1601830) Issuer Taylor Ben R (1712276) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 09/10/2026 4:55 PM | Khan Najat (2020969) Reporting Recursion Pharmaceuticals (1601830) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 09/08/2026 1:28 PM | Khan Najat (2020969) Reporting Recursion Pharmaceuticals (1601830) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 09/02/2026 5:01 PM | Borgeson Blake (1856094) Reporting Recursion Pharmaceuticals (1601830) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 09/01/2026 3:21 PM | Borgeson Blake (1856094) Reporting Recursion Pharmaceuticals (1601830) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 08/21/2026 10:27 AM | Gibson Christopher (1856369) Reporting Recursion Pharmaceuticals (1601830) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 08/20/2026 10:32 AM | Gibson Christopher (1856369) Reporting Recursion Pharmaceuticals (1601830) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 08/19/2026 10:54 AM | Gibson Christopher (1856369) Reporting Recursion Pharmaceuticals (1601830) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 08/18/2026 4:44 PM | Recursion Pharmaceuticals (1601830) Issuer Taylor Ben R (1712276) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 08/18/2026 4:44 PM | Hallett David (2006495) Reporting Recursion Pharmaceuticals (1601830) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 08/18/2026 4:44 PM | Khan Najat (2020969) Reporting Recursion Pharmaceuticals (1601830) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 08/18/2026 4:14 PM | Gibson Christopher (1856369) Reporting Recursion Pharmaceuticals (1601830) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 08/13/2026 11:58 AM | Gibson Christopher (1856369) Reporting Recursion Pharmaceuticals (1601830) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 08/12/2026 10:56 AM | Gibson Christopher (1856369) Reporting Recursion Pharmaceuticals (1601830) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 08/10/2026 3:59 PM | Gibson Christopher (1856369) Reporting Recursion Pharmaceuticals (1601830) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 08/07/2026 11:42 AM | Gibson Christopher (1856369) Reporting Recursion Pharmaceuticals (1601830) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 08/07/2026 9:48 AM | Recursion Pharmaceuticals (1601830) Subject STATE STREET CORP (93751) Filed by STATE STREET CORP (93751) Filed by | Form SCHEDULE 13G | |
| 08/06/2026 4:09 PM | Borgeson Blake (1856094) Reporting Recursion Pharmaceuticals (1601830) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 08/05/2026 5:31 AM | Recursion Pharmaceuticals (1601830) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 08/05/2026 5:32 AM | Recursion Pharmaceuticals (1601830) Filer | Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
| 08/04/2026 12:37 PM | Borgeson Blake (1856094) Reporting Recursion Pharmaceuticals (1601830) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 08/04/2026 9:35 AM | Gibson Christopher (1856369) Reporting Recursion Pharmaceuticals (1601830) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 07/31/2026 10:40 AM | Recursion Pharmaceuticals (1601830) Subject VANGUARD PORTFOLIO MANAGEMENT LLC (2100121) Filed by | Form SCHEDULE 13G | |
Don't lose access to this (Ad) Ian Cooper is giving away his guide, The Simple Path To Success With Options, before it moves behind a paywall.
The free download walks through strategies for navigating the options market, but the window to claim it is closing soon. Download your free copy before access ends for good |
| 07/31/2026 9:42 AM | Recursion Pharmaceuticals (1601830) Subject VANGUARD CAPITAL MANAGEMENT LLC (2100119) Filed by | Form SCHEDULE 13G | |
| 07/30/2026 3:10 PM | Gibson Christopher (1856369) Reporting Recursion Pharmaceuticals (1601830) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 07/21/2026 3:11 PM | Gibson Christopher (1856369) Reporting Recursion Pharmaceuticals (1601830) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 07/20/2026 3:11 PM | Gibson Christopher (1856369) Reporting Recursion Pharmaceuticals (1601830) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 07/17/2026 3:10 PM | Gibson Christopher (1856369) Reporting Recursion Pharmaceuticals (1601830) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 07/16/2026 3:13 PM | Gibson Christopher (1856369) Reporting Recursion Pharmaceuticals (1601830) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 07/15/2026 3:12 PM | Gibson Christopher (1856369) Reporting Recursion Pharmaceuticals (1601830) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 07/14/2026 3:07 PM | Gibson Christopher (1856369) Reporting Recursion Pharmaceuticals (1601830) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 07/13/2026 3:32 PM | Gibson Christopher (1856369) Reporting Recursion Pharmaceuticals (1601830) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 07/10/2026 3:09 PM | Gibson Christopher (1856369) Reporting Recursion Pharmaceuticals (1601830) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 07/09/2026 5:04 PM | Borgeson Blake (1856094) Reporting Recursion Pharmaceuticals (1601830) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 07/09/2026 3:26 PM | Gibson Christopher (1856369) Reporting Recursion Pharmaceuticals (1601830) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 07/08/2026 3:26 PM | Gibson Christopher (1856369) Reporting Recursion Pharmaceuticals (1601830) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 07/07/2026 12:39 PM | Gibson Christopher (1856369) Reporting Recursion Pharmaceuticals (1601830) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 07/07/2026 10:36 AM | Borgeson Blake (1856094) Reporting Recursion Pharmaceuticals (1601830) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 07/06/2026 2:28 PM | Gibson Christopher (1856369) Reporting Recursion Pharmaceuticals (1601830) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 07/02/2026 4:15 PM | Li Dean Y (1837016) Reporting Recursion Pharmaceuticals (1601830) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 07/02/2026 4:15 PM | Dar Zavain (1852075) Reporting Recursion Pharmaceuticals (1601830) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 07/02/2026 11:54 AM | Gibson Christopher (1856369) Reporting Recursion Pharmaceuticals (1601830) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 07/01/2026 4:19 PM | Gibson Christopher (1856369) Reporting Recursion Pharmaceuticals (1601830) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 06/22/2026 3:32 PM | Bumpus Namandje (2060594) Reporting Recursion Pharmaceuticals (1601830) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/22/2026 3:32 PM | Li Dean Y (1837016) Reporting Recursion Pharmaceuticals (1601830) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/22/2026 3:32 PM | Dar Zavain (1852075) Reporting Recursion Pharmaceuticals (1601830) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/22/2026 3:32 PM | Recursion Pharmaceuticals (1601830) Issuer Sun Elaine D (1805339) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/22/2026 3:32 PM | Michor Franziska (2045159) Reporting Recursion Pharmaceuticals (1601830) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/22/2026 3:32 PM | HERSHBERG ROBERT (1274139) Reporting Recursion Pharmaceuticals (1601830) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/22/2026 3:32 PM | Borgeson Blake (1856094) Reporting Recursion Pharmaceuticals (1601830) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/18/2026 4:04 PM | Recursion Pharmaceuticals (1601830) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 06/18/2026 3:33 PM | Gibson Christopher (1856369) Reporting Recursion Pharmaceuticals (1601830) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 06/18/2026 8:37 AM | Gibson Christopher (1856369) Reporting Recursion Pharmaceuticals (1601830) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 06/18/2026 8:44 AM | Bumpus Namandje (2060594) Reporting Recursion Pharmaceuticals (1601830) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 06/17/2026 4:07 PM | Recursion Pharmaceuticals (1601830) Issuer Taylor Ben R (1712276) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/05/2026 4:02 PM | Khan Najat (2020969) Reporting Recursion Pharmaceuticals (1601830) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/05/2026 4:03 PM | Gibson Christopher (1856369) Reporting Recursion Pharmaceuticals (1601830) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/05/2026 12:29 PM | Khan Najat (2020969) Reporting Recursion Pharmaceuticals (1601830) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 06/05/2026 9:19 AM | Gibson Christopher (1856369) Reporting Recursion Pharmaceuticals (1601830) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 06/04/2026 4:04 PM | Borgeson Blake (1856094) Reporting Recursion Pharmaceuticals (1601830) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/04/2026 4:04 PM | Bumpus Namandje (2060594) Reporting Recursion Pharmaceuticals (1601830) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/03/2026 9:16 AM | Bumpus Namandje (2060594) Reporting Recursion Pharmaceuticals (1601830) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 06/02/2026 10:04 AM | Borgeson Blake (1856094) Reporting Recursion Pharmaceuticals (1601830) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 05/27/2026 3:15 PM | Gibson Christopher (1856369) Reporting Recursion Pharmaceuticals (1601830) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/22/2026 9:13 AM | Gibson Christopher (1856369) Reporting Recursion Pharmaceuticals (1601830) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 05/19/2026 4:54 PM | Gibson Christopher (1856369) Reporting Recursion Pharmaceuticals (1601830) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/19/2026 4:54 PM | Recursion Pharmaceuticals (1601830) Issuer Taylor Ben R (1712276) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/19/2026 4:54 PM | Khan Najat (2020969) Reporting Recursion Pharmaceuticals (1601830) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/19/2026 4:54 PM | Hallett David (2006495) Reporting Recursion Pharmaceuticals (1601830) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/12/2026 10:53 AM | Recursion Pharmaceuticals (1601830) Subject STATE STREET CORP (93751) Filed by STATE STREET CORP (93751) Filed by | Form SCHEDULE 13G | |
| 05/08/2026 3:59 PM | Gibson Christopher (1856369) Reporting Recursion Pharmaceuticals (1601830) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/07/2026 3:44 PM | Borgeson Blake (1856094) Reporting Recursion Pharmaceuticals (1601830) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/07/2026 10:13 AM | Gibson Christopher (1856369) Reporting Recursion Pharmaceuticals (1601830) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
Drop these 5 stocks before the market opens tomorrow! (Ad) The Wall Street Journal called it the "$64 trillion question": is a stock market crash on the way? Weiss Ratings' latest research says 2026 could be very rough for some well-known stocks.
A major shift now taking shape in the market could hit some of America's most-loved names hard. Weiss analysts have pinpointed five stocks they believe investors should steer clear of while it plays out. See the five stocks Weiss Ratings analysts are watching closely now. |
| 05/06/2026 5:31 AM | Recursion Pharmaceuticals (1601830) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 05/06/2026 5:32 AM | Recursion Pharmaceuticals (1601830) Filer | Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
| 05/05/2026 9:22 AM | Borgeson Blake (1856094) Reporting Recursion Pharmaceuticals (1601830) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 04/30/2026 3:31 PM | Recursion Pharmaceuticals (1601830) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 04/30/2026 3:33 PM | Recursion Pharmaceuticals (1601830) Filer | Form DEF 14A | |
| 04/30/2026 3:34 PM | Recursion Pharmaceuticals (1601830) Filer | Form DEFA14A | |
| 04/30/2026 3:35 PM | Recursion Pharmaceuticals (1601830) Filer | Form ARS | |
| 04/22/2026 8:47 AM | Gibson Christopher (1856369) Reporting Recursion Pharmaceuticals (1601830) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 04/08/2026 3:58 PM | Borgeson Blake (1856094) Reporting Recursion Pharmaceuticals (1601830) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |